HOME >> MEDICINE >> NEWS
Trial reveals safer and simpler approach to treating children with cystic fibrosis

Treating chest infections in young cystic fibrosis patients with an antibiotic once instead of three times daily is as effective and less toxic, conclude the results of a randomised trial published in this week's issue of THE LANCET.

Aminoglycoside antibiotics are widely used for the management of patients who have cystic fibrosis and chronic chest infection with a bacterium called Pseudomonas aerginosa. Currently patients are given aminoglycosides three times daily. The drugs can cause damage to kidney function and hearing loss.

Alan Smyth (University of Nottingham, UK) and colleagues recruited 219 cystic fibrosis patients (125 children and 94 adults) between 1999 and 2003 in the UK. The patients were randomly assigned to receive an aminoglycoside called tobramycin intravenously once or three times daily for 14 days. The researchers measured changes in lung function and found that the two treatments had a similar effect. However in children, the once daily treatment caused fewer kidney related side effects.

Dr Alan Smyth comments: "Our results are likely to affect aminoglycoside prescription in cystic fibrosis in clinical practice. Once daily treatment may be preferred by patients receiving intravenous antibiotics because of its convenience. Antipseudomonal antibiotics are usually given as combinations of two or more drugs in cystic fibrosis because of concerns of emerging antibiotic resistance. Most other antipseudomonal antibiotics need to be given three times daily and so further development of other once daily antibiotics would be useful."

In an accompanying commentary Heather VandenBussche (Bronson Methodist Hospital, Michigan, USA) and Michael Klepser (Ferris State University College of Pharmacy, Michigan, USA) write that several unanswered questions persist about once daily aminoglycoside dosing in cystic fibrosis patients.

Dr VandenBussche concludes: " Smyth and colleagues' report provides some useful insights into
'"/>

Contact: Joe Santangelo
j.santangelo@elsevier.com
1-212-633-3810
Lancet
10-Feb-2005


Page: 1 2

Related medicine news :

1. Trials launched to test treatment of cognitive dysfunction in schizophrenia
2. Randomisation phase of the DIRECT programme (DIabetic REtinopathy Candesartan Trials) completed
3. Trials on hormone therapy and hypertension treatment change practice, medication usage of patients
4. Trial results have dramatically reduced HRT use
5. Release of results of Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
6. Trial opens new possibilities for improving survival with a novel heart attack drug
7. Clinical Trials Litigation: Legal & Ethical Issues in Human Subjects Research
8. National Lung Screening Trial
9. New awards, expanded focus for Pediatric AIDS Clinical Trials Group
10. AAPS Workshop to Examine Chemistry and Manufacturing Controls Trials, Emerging Products
11. Abgenix Reports Positive Survival Data From A Phase II Trial Of ABX-CBL In Graft Versus Host Disease

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/15/2019)... , ... January 15, 2019 , ... Celebrating the 25th ... its first mascot – the Pumas – to almost 2,000 employees and 150 students ... Ultimate Learning Center, Inc. At that time, UMA was a single campus with 25 ...
(Date:1/14/2019)... ... January 14, 2019 , ... LifeLearn Animal ... Veterinary Community (NAVC) and will be partnering with NAVC to deliver an all-new ... veterinary students, veterinary nurses/technicians, practice managers and practice staff. , “We’re excited by ...
(Date:1/14/2019)... ... January 14, 2019 , ... Modere (the “Company”), ... with a presence worldwide, today announced that it built on 2017’s growth momentum, ... grew by double-digits in North America, by more than five times in Europe ...
(Date:1/14/2019)... ... January 15, 2019 , ... ... Inflammatory Bowel and Colorectal Diseases, Institute for Digestive Health & Liver Disease ... for treating hemorrhoids., A specially designed instrument known as a suction hemorrhoid ligator ...
(Date:1/14/2019)... ... January 14, 2019 , ... Trees can be overweight ... homeowners should have trees pruned, and winter is a great time to clean things ... branches can lead to serious damage, especially during windy or icy storms. The crown ...
Breaking Medicine News(10 mins):
(Date:1/7/2019)... SAN FRANCISCO (PRWEB) , ... January 07, 2019 , ... ... story which provides insights to help individuals understand how their gut microbes offer support ... play a role in how long the toxic byproducts of breakdown linger in your ...
(Date:1/7/2019)... (PRWEB) , ... January 07, 2019 , ... Brighton Foot and Ankle Podiatry has been ... This year again we have the most reviews , and the best review average on ... one ranked choice of the Brighton St. Joseph Mercy Hospital, and Livingston St. Joseph Mercy ...
(Date:1/5/2019)... Ariz. (PRWEB) , ... January 04, 2019 , ... ... and be seen by potential investors! WearRAcon is scheduled to take ... Robotics Association (WearRA) is inviting entries that represent the most innovative new ideas ...
Breaking Medicine Technology:
Cached News: